Literature DB >> 9000057

A human protein required for the second step of pre-mRNA splicing is functionally related to a yeast splicing factor.

D S Horowitz1, A R Krainer.   

Abstract

We have identified a human splicing factor required for the second step of pre-mRNA splicing. This new protein, hPrp18, is 30% identical to the yeast splicing factor Prp18. In HeLa cell extracts immunodepleted of hPrp18, the second step of pre-mRNA splicing is abolished. Splicing activity is restored by the addition of recombinant hPrp18, demonstrating that hPrp18 is required for the second step. The hPrp18 protein is bound tightly to the spliceosome only during the second step of splicing. hPrp18 is required for the splicing of several pre-mRNAs, making it the first general second-step splicing factor found in humans. Splicing activity can be restored to hPrp18-depleted HeLa cell extracts by yeast Prp18, showing that important functional regions of the proteins have been conserved. A 90-amino-acid region near the carboxyl terminus of hPrp18 is strongly homologous to yeast Prp18 and is also conserved in rice and nematodes. The homology identifies one region important for the function of both proteins and may define a new protein motif. In contrast to yeast Prp18, hPrp18 is not stably associated with any of the snRNPs. A 55-kD protein that cross-reacts with antibodies against hPrp18 is a constituent of the U4/U6 and U4/U6 x U5 snRNP particles.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9000057     DOI: 10.1101/gad.11.1.139

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  35 in total

1.  Purification of the yeast U4/U6.U5 small nuclear ribonucleoprotein particle and identification of its proteins.

Authors:  S W Stevens; J Abelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  Evidence for a linear search in bimolecular 3' splice site AG selection.

Authors:  S Chen; K Anderson; M J Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis.

Authors:  Melissa S Jurica; Lawrence J Licklider; Steven R Gygi; Nikolaus Grigorieff; Melissa J Moore
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

4.  PSF and p54nrb bind a conserved stem in U5 snRNA.

Authors:  Rui Peng; Billy T Dye; Ismael Pérez; Daron C Barnard; Amanda B Thompson; James G Patton
Journal:  RNA       Date:  2002-10       Impact factor: 4.942

5.  Reversible inhibition of the second step of splicing suggests a possible role of zinc in the second step of splicing.

Authors:  Noam Shomron; Hadar Malca; Ida Vig; Gil Ast
Journal:  Nucleic Acids Res       Date:  2002-10-01       Impact factor: 16.971

6.  Protein composition and electron microscopy structure of affinity-purified human spliceosomal B complexes isolated under physiological conditions.

Authors:  Jochen Deckert; Klaus Hartmuth; Daniel Boehringer; Nastaran Behzadnia; Cindy L Will; Berthold Kastner; Holger Stark; Henning Urlaub; Reinhard Lührmann
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

7.  Splicing remodels messenger ribonucleoprotein architecture via eIF4A3-dependent and -independent recruitment of exon junction complex components.

Authors:  Zuo Zhang; Adrian R Krainer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-02       Impact factor: 11.205

Review 8.  Spliceosomal immunophilins.

Authors:  Annia Mesa; Jason A Somarelli; Rene J Herrera
Journal:  FEBS Lett       Date:  2008-06-09       Impact factor: 4.124

9.  Genetic and functional interaction of evolutionarily conserved regions of the Prp18 protein and the U5 snRNA.

Authors:  Dagmar Bacíková; David S Horowitz
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

10.  The mammalian homologue of Prp16p is overexpressed in a cell line tolerant to Leflunomide, a new immunoregulatory drug effective against rheumatoid arthritis.

Authors:  D Ortlepp; B Laggerbauer; S Müllner; T Achsel; B Kirschbaum; R Lührmann
Journal:  RNA       Date:  1998-08       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.